- Report
- July 2025
- 384 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 578 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 172 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 372 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 184 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 382 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 392 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 294 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- April 2025
- 175 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- April 2025
- 250 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- April 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- April 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- April 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- March 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- February 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- February 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- February 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- February 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,436GBP
- Report
- July 2025
- 385 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 553 Pages
Global
From €5158EUR$5,850USD£4,477GBP

Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs.
The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience.
Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more